Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Netripples Software's EBITDA for the
three
months ended in Mar. 2026 was ₹-1.17 Mil. Netripples Software's Revenue for the
three
months ended in Mar. 2026 was ₹26.84 Mil. Therefore, Netripples Software's EBITDA margin for the quarter that ended in Mar. 2026 was -4.36%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Netripples Software EBITDA Margin % Related Terms
Netripples Software EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Netripples Software's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542117 vs CERN, VEEV, CHNG: EBITDA Margin % Comparison
For the Health Information Services subindustry, Netripples Software's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Netripples Software EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Netripples Software's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Netripples Software's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Netripples Software (BOM:542117) has a EBITDA Margin % of -4.36% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Netripples Software and its competitors. Over the past decade, Netripples Software's EBITDA Margin % has ranged from 0.61 to 23.84.
Is Netripples Software's EBITDA Margin % too high?
Netripples Software's current EBITDA Margin % is -4.36%. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 23.84.
How does Netripples Software's EBITDA Margin % compare to CERN and VEEV?
Netripples Software's EBITDA Margin % of -4.36% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.24. Historically, Netripples Software's own EBITDA Margin % has ranged from 0.61 to 23.84 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Netripples Software and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Netripples Software's current EBITDA Margin % is -4.36%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Netripples Software stock overvalued right now?
Netripples Software (BOM:542117) has a current EBITDA Margin % of -4.36%. The stock's GF Value™ is ₹1.58, compared to a current price of ₹5.51 — trading 248.7% above its estimated fair value. The current EBITDA Margin % is -4.36%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Netripples Software (BOM:542117), the current EBITDA Margin % is -4.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Netripples Software Ltd offers to consult in technology and outsourcing and next-generation services with a focus on healthcare and education. The company operates in a Single Segment that is Application Software and services. The company provides ready to use healthcare informatics products, outsourcing on healthcare and education, supply chain software development, consulting on blood bank and blood bank networking, data migration, data storage, data center management and infrastructure services, online and E-commerce Store Setup, establishment, and training and deployments.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542117 has been successfully added to your 
